CN Stock MarketDetailed Quotes

300519 Zhejiang Xinguang Pharmaceutical

Watchlist
  • 14.71
  • +0.16+1.10%
Trading Nov 5 13:04 CST
2.35BMarket Cap54.28P/E (TTM)

Zhejiang Xinguang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
0.05%216.21M
-1.90%146.21M
8.94%100.55M
-23.07%270.4M
-17.66%216.11M
-12.57%149.04M
-9.42%92.3M
9.54%351.49M
6.57%262.45M
6.87%170.46M
Operating revenue
0.05%216.21M
-1.90%146.21M
8.94%100.55M
-23.07%270.4M
-17.66%216.11M
-12.57%149.04M
-9.42%92.3M
9.54%351.49M
6.57%262.45M
6.87%170.46M
Other operating revenue
----
5.26%57.5K
----
-1.33%114.97K
----
-0.40%54.63K
----
8.28%116.52K
----
7.12%54.84K
Total operating cost
17.69%177.85M
13.42%121.64M
31.49%76.15M
-11.51%203.77M
-5.74%151.12M
4.64%107.24M
9.46%57.91M
18.03%230.27M
10.66%160.33M
8.10%102.49M
Operating cost
18.34%140.36M
21.98%96.5M
39.32%62.81M
-6.17%158.8M
-1.20%118.61M
1.99%79.11M
3.32%45.09M
19.07%169.23M
15.58%120.04M
16.18%77.57M
Operating tax surcharges
48.38%3.51M
38.40%2.33M
45.75%1.65M
2.40%4.36M
-23.28%2.37M
-13.20%1.68M
-5.35%1.13M
0.85%4.26M
-1.98%3.08M
-3.77%1.94M
Operating expense
-7.71%16.94M
-10.27%11.47M
9.47%5.96M
-21.59%26.45M
-13.35%18.36M
-12.31%12.78M
-18.27%5.45M
5.23%33.74M
-1.22%21.18M
-2.14%14.57M
Administration expense
-10.42%11.72M
-5.37%8.24M
-7.16%3.68M
3.84%17.92M
2.13%13.09M
0.74%8.71M
2.38%3.96M
-12.63%17.26M
-3.56%12.82M
-1.27%8.65M
Financial expense
66.99%-4.31M
-41.97%-3.86M
-46.56%-1.89M
-93.45%-18.89M
-54.12%-13.07M
64.32%-2.72M
79.92%-1.29M
41.16%-9.77M
-34.18%-8.48M
-89.33%-7.61M
-Interest Income (Financial expense)
66.94%-4.32M
-41.80%-3.86M
-46.48%-1.89M
----
-54.07%-13.08M
64.24%-2.72M
79.89%-1.29M
----
-34.11%-8.49M
-89.15%-7.62M
Research and development
-18.23%9.62M
-9.35%6.96M
10.17%3.95M
-2.67%15.13M
0.75%11.76M
4.08%7.67M
-9.71%3.58M
15.01%15.55M
23.55%11.68M
15.14%7.37M
Credit Impairment Loss
-206.35%-390.43K
-100.33%-1.98K
-84.93%121.76K
263.74%708.14K
262.69%367.11K
522.28%604.9K
150.00%808.08K
-366.27%-432.48K
-31.76%-225.65K
-39.99%97.21K
Asset Impairment Loss
55.89%-213.49K
67.37%-197.91K
-65.27%-377.44K
-153.43%-503.34K
-6.51%-483.94K
-160.57%-606.47K
-590.06%-228.37K
68.20%-198.61K
-75.57%-454.36K
27.54%-232.75K
Other net revenue
-2.18%4.97M
7.64%3.81M
10.20%1.62M
39.40%7.51M
33.85%5.08M
1.77%3.54M
9.91%1.47M
-20.77%5.38M
-34.83%3.8M
49.86%3.48M
Invest income
13.95%3.62M
22.90%2.49M
109.15%1.1M
-5.63%4.07M
3.78%3.17M
-18.42%2.03M
-13.19%523.93K
-32.75%4.32M
-39.40%3.06M
61.38%2.48M
Asset deal income
-621.97%-67.85K
-621.97%-67.85K
-621.97%-67.85K
---290.57K
--13K
--13K
--13K
----
----
----
Other revenue
0.72%2.02M
5.71%1.59M
141.02%844.2K
106.96%3.52M
41.86%2.01M
32.89%1.5M
-20.57%350.26K
9.42%1.7M
17.42%1.42M
20.10%1.13M
Operating profit
-38.16%43.33M
-37.39%28.38M
-27.45%26.01M
-41.45%74.13M
-33.84%70.08M
-36.55%45.33M
-28.76%35.85M
-4.51%126.6M
-1.21%105.92M
6.63%71.45M
Add:Non operating Income
3,662.18%300.97K
3,662.18%300.97K
2,255.93%188.47K
123.09%31.24K
-42.88%8K
-42.88%8K
-42.88%8K
-60.34%14.01K
-60.34%14.01K
-60.34%14.01K
Less:Non operating expense
0.67%1.01M
--6.7K
--6.7K
-1.06%1M
-1.47%1M
----
----
53.46%1.01M
-73.55%1.01M
--14.94K
Total profit
-38.30%42.63M
-36.75%28.68M
-26.96%26.19M
-41.75%73.16M
-34.15%69.09M
-36.54%45.34M
-28.76%35.86M
-4.82%125.6M
1.46%104.92M
6.57%71.45M
Less:Income tax cost
-53.35%4.84M
-53.41%3.17M
-37.93%3.36M
-47.54%8.8M
-33.09%10.39M
-36.09%6.8M
-28.00%5.41M
-5.06%16.78M
0.56%15.52M
6.16%10.65M
Net profit
-35.63%37.78M
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
Net profit from continuing operation
-35.63%37.78M
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
Net profit of parent company owners
-35.63%37.78M
-33.81%25.51M
-25.01%22.83M
-40.86%64.36M
-34.34%58.7M
-36.62%38.54M
-28.90%30.45M
-4.78%108.82M
1.61%89.4M
6.65%60.8M
Earning per share
Basic earning per share
-35.14%0.24
-33.33%0.16
-26.32%0.14
-41.18%0.4
-33.93%0.37
-36.84%0.24
-29.63%0.19
-4.23%0.68
1.82%0.56
5.56%0.38
Diluted earning per share
-35.14%0.24
-33.33%0.16
-26.32%0.14
-41.18%0.4
-33.93%0.37
-36.84%0.24
-29.63%0.19
-4.23%0.68
1.82%0.56
5.56%0.38
Other composite income
-96.13%16.61K
-169.19%-231.39K
-404.10%-407.24K
705.96%869.74K
240.11%429.7K
10,126.03%334.44K
-35.17%133.92K
-140.55%-143.53K
-562.59%-306.68K
-101.99%-3.34K
Other composite income of parent company owners
-96.13%16.61K
-169.19%-231.39K
-404.10%-407.24K
705.96%869.74K
240.11%429.7K
10,126.03%334.44K
-35.17%133.92K
-140.55%-143.53K
-562.59%-306.68K
-101.99%-3.34K
Total composite income
-36.07%37.8M
-34.98%25.28M
-26.67%22.42M
-39.98%65.23M
-33.63%59.13M
-36.06%38.87M
-28.93%30.58M
-5.20%108.68M
1.19%89.09M
6.33%60.8M
Total composite income of parent company owners
-36.07%37.8M
-34.98%25.28M
-26.67%22.42M
-39.98%65.23M
-33.63%59.13M
-36.06%38.87M
-28.93%30.58M
-5.20%108.68M
1.19%89.09M
6.33%60.8M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 0.05%216.21M-1.90%146.21M8.94%100.55M-23.07%270.4M-17.66%216.11M-12.57%149.04M-9.42%92.3M9.54%351.49M6.57%262.45M6.87%170.46M
Operating revenue 0.05%216.21M-1.90%146.21M8.94%100.55M-23.07%270.4M-17.66%216.11M-12.57%149.04M-9.42%92.3M9.54%351.49M6.57%262.45M6.87%170.46M
Other operating revenue ----5.26%57.5K-----1.33%114.97K-----0.40%54.63K----8.28%116.52K----7.12%54.84K
Total operating cost 17.69%177.85M13.42%121.64M31.49%76.15M-11.51%203.77M-5.74%151.12M4.64%107.24M9.46%57.91M18.03%230.27M10.66%160.33M8.10%102.49M
Operating cost 18.34%140.36M21.98%96.5M39.32%62.81M-6.17%158.8M-1.20%118.61M1.99%79.11M3.32%45.09M19.07%169.23M15.58%120.04M16.18%77.57M
Operating tax surcharges 48.38%3.51M38.40%2.33M45.75%1.65M2.40%4.36M-23.28%2.37M-13.20%1.68M-5.35%1.13M0.85%4.26M-1.98%3.08M-3.77%1.94M
Operating expense -7.71%16.94M-10.27%11.47M9.47%5.96M-21.59%26.45M-13.35%18.36M-12.31%12.78M-18.27%5.45M5.23%33.74M-1.22%21.18M-2.14%14.57M
Administration expense -10.42%11.72M-5.37%8.24M-7.16%3.68M3.84%17.92M2.13%13.09M0.74%8.71M2.38%3.96M-12.63%17.26M-3.56%12.82M-1.27%8.65M
Financial expense 66.99%-4.31M-41.97%-3.86M-46.56%-1.89M-93.45%-18.89M-54.12%-13.07M64.32%-2.72M79.92%-1.29M41.16%-9.77M-34.18%-8.48M-89.33%-7.61M
-Interest Income (Financial expense) 66.94%-4.32M-41.80%-3.86M-46.48%-1.89M-----54.07%-13.08M64.24%-2.72M79.89%-1.29M-----34.11%-8.49M-89.15%-7.62M
Research and development -18.23%9.62M-9.35%6.96M10.17%3.95M-2.67%15.13M0.75%11.76M4.08%7.67M-9.71%3.58M15.01%15.55M23.55%11.68M15.14%7.37M
Credit Impairment Loss -206.35%-390.43K-100.33%-1.98K-84.93%121.76K263.74%708.14K262.69%367.11K522.28%604.9K150.00%808.08K-366.27%-432.48K-31.76%-225.65K-39.99%97.21K
Asset Impairment Loss 55.89%-213.49K67.37%-197.91K-65.27%-377.44K-153.43%-503.34K-6.51%-483.94K-160.57%-606.47K-590.06%-228.37K68.20%-198.61K-75.57%-454.36K27.54%-232.75K
Other net revenue -2.18%4.97M7.64%3.81M10.20%1.62M39.40%7.51M33.85%5.08M1.77%3.54M9.91%1.47M-20.77%5.38M-34.83%3.8M49.86%3.48M
Invest income 13.95%3.62M22.90%2.49M109.15%1.1M-5.63%4.07M3.78%3.17M-18.42%2.03M-13.19%523.93K-32.75%4.32M-39.40%3.06M61.38%2.48M
Asset deal income -621.97%-67.85K-621.97%-67.85K-621.97%-67.85K---290.57K--13K--13K--13K------------
Other revenue 0.72%2.02M5.71%1.59M141.02%844.2K106.96%3.52M41.86%2.01M32.89%1.5M-20.57%350.26K9.42%1.7M17.42%1.42M20.10%1.13M
Operating profit -38.16%43.33M-37.39%28.38M-27.45%26.01M-41.45%74.13M-33.84%70.08M-36.55%45.33M-28.76%35.85M-4.51%126.6M-1.21%105.92M6.63%71.45M
Add:Non operating Income 3,662.18%300.97K3,662.18%300.97K2,255.93%188.47K123.09%31.24K-42.88%8K-42.88%8K-42.88%8K-60.34%14.01K-60.34%14.01K-60.34%14.01K
Less:Non operating expense 0.67%1.01M--6.7K--6.7K-1.06%1M-1.47%1M--------53.46%1.01M-73.55%1.01M--14.94K
Total profit -38.30%42.63M-36.75%28.68M-26.96%26.19M-41.75%73.16M-34.15%69.09M-36.54%45.34M-28.76%35.86M-4.82%125.6M1.46%104.92M6.57%71.45M
Less:Income tax cost -53.35%4.84M-53.41%3.17M-37.93%3.36M-47.54%8.8M-33.09%10.39M-36.09%6.8M-28.00%5.41M-5.06%16.78M0.56%15.52M6.16%10.65M
Net profit -35.63%37.78M-33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M
Net profit from continuing operation -35.63%37.78M-33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M
Net profit of parent company owners -35.63%37.78M-33.81%25.51M-25.01%22.83M-40.86%64.36M-34.34%58.7M-36.62%38.54M-28.90%30.45M-4.78%108.82M1.61%89.4M6.65%60.8M
Earning per share
Basic earning per share -35.14%0.24-33.33%0.16-26.32%0.14-41.18%0.4-33.93%0.37-36.84%0.24-29.63%0.19-4.23%0.681.82%0.565.56%0.38
Diluted earning per share -35.14%0.24-33.33%0.16-26.32%0.14-41.18%0.4-33.93%0.37-36.84%0.24-29.63%0.19-4.23%0.681.82%0.565.56%0.38
Other composite income -96.13%16.61K-169.19%-231.39K-404.10%-407.24K705.96%869.74K240.11%429.7K10,126.03%334.44K-35.17%133.92K-140.55%-143.53K-562.59%-306.68K-101.99%-3.34K
Other composite income of parent company owners -96.13%16.61K-169.19%-231.39K-404.10%-407.24K705.96%869.74K240.11%429.7K10,126.03%334.44K-35.17%133.92K-140.55%-143.53K-562.59%-306.68K-101.99%-3.34K
Total composite income -36.07%37.8M-34.98%25.28M-26.67%22.42M-39.98%65.23M-33.63%59.13M-36.06%38.87M-28.93%30.58M-5.20%108.68M1.19%89.09M6.33%60.8M
Total composite income of parent company owners -36.07%37.8M-34.98%25.28M-26.67%22.42M-39.98%65.23M-33.63%59.13M-36.06%38.87M-28.93%30.58M-5.20%108.68M1.19%89.09M6.33%60.8M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data